Speranza Rubattu Selected Research

Atrial Natriuretic Factor (ANF)

1/2022	The Natriuretic Peptides for Hypertension Treatment.
12/2021	Novel ANP (Atrial Natriuretic Peptide)-Based Therapy for Hypertension: The Promising Role of a Disease Mechanism Targeted Approach.
1/2021	T2238C atrial natriuretic peptide gene variant and cardiovascular events in patients with atrial fibrillation: A substudy from the ATHERO-AF cohort.
11/2019	Atrial natriuretic peptide predicts disease progression and digital ulcers development in systemic sclerosis patients.
2/2019	Molecular Implications of Natriuretic Peptides in the Protection from Hypertension and Target Organ Damage Development.
2/2018	The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases.
1/2018	T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients.
1/2018	Effects of dual angiotensin type 1 receptor/neprilysin inhibition vs. angiotensin type 1 receptor inhibition on target organ injury in the stroke-prone spontaneously hypertensive rat.
1/2017	C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP.
8/2016	T2238C ANP gene variant and risk of recurrent acute coronary syndromes in an Italian cohort of ischemic heart disease patients.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Speranza Rubattu Research Topics

Disease

29	Stroke (Strokes) 01/2022 - 11/2002
27	Hypertension (High Blood Pressure) 01/2022 - 11/2002
18	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2006
16	Heart Failure 11/2021 - 11/2002
7	Acute Coronary Syndrome 01/2022 - 05/2012
6	Ischemic Stroke 05/2022 - 04/2004
6	Inflammation (Inflammations) 01/2017 - 03/2009
5	Atherosclerosis 11/2021 - 09/2009
5	Myocardial Infarction 11/2021 - 11/2002
5	Vascular Diseases (Vascular Disease) 10/2021 - 04/2004
5	Coronary Artery Disease (Coronary Atherosclerosis) 08/2016 - 09/2009
4	Atrial Fibrillation 01/2021 - 01/2013
3	Mitochondrial Diseases (Mitochondrial Disease) 01/2022 - 12/2014
3	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 05/2020 - 01/2010
3	Stable Angina 01/2019 - 05/2012
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2018 - 08/2016
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2017 - 10/2004
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 02/2014 - 01/2006
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 11/2009 - 04/2007
2	COVID-19 01/2021 - 01/2020
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2021 - 08/2010
2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 11/2019
2	Cardiomyopathies (Cardiomyopathy) 12/2020 - 09/2009
2	Fibrosis (Cirrhosis) 01/2018 - 11/2013
2	Essential Hypertension 06/2015 - 08/2006
2	Ventricular Tachycardia 06/2015 - 12/2013
2	Cardiomegaly (Heart Hypertrophy) 12/2014 - 01/2010
2	Vascular Remodeling 09/2009 - 01/2007
2	Obesity 07/2008 - 04/2007
1	Metabolic Diseases (Metabolic Disease) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Pathologic Processes 07/2020
1	Cognitive Dysfunction 07/2020
1	Dementia (Dementias) 07/2020
1	Mitral Valve Insufficiency (Mitral Regurgitation) 05/2020
1	Disease Progression 11/2019
1	digital ulcers 11/2019
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2019
1	Thrombosis (Thrombus) 10/2018
1	Body Weight (Weight, Body) 01/2018
1	Infarction (Infarctions) 01/2018
1	Proteinuria 01/2018

Drug/Important Bio-Agent (IBA)

24	Atrial Natriuretic Factor (ANF)IBA 01/2022 - 02/2004
19	Natriuretic PeptidesIBA 01/2022 - 04/2004
10	SaltsIBA 11/2021 - 10/2006
10	Proteins (Proteins, Gene)FDA Link 06/2020 - 11/2009
8	Uncoupling Protein 2IBA 05/2022 - 02/2013
6	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 09/2009
6	Biomarkers (Surrogate Marker)IBA 01/2019 - 11/2010
6	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2017 - 09/2009
5	PotassiumIBA 01/2017 - 10/2006
4	AntioxidantsIBA 01/2019 - 02/2013
3	Messenger RNA (mRNA)IBA 01/2022 - 08/2015
3	sacubitril and valsartan sodium hydrate drug combinationIBA 11/2021 - 01/2018
3	Adenosine Triphosphate (ATP)IBA 01/2021 - 02/2016
3	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2019 - 08/2006
3	NADPH Oxidases (NAD(P)H oxidase)IBA 02/2017 - 08/2003
2	CalciumIBA 01/2022 - 12/2013
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022 - 12/2014
2	TrehaloseIBA 11/2021 - 01/2018
2	DisaccharidesIBA 11/2021 - 01/2018
2	Hormones (Hormone)IBA 01/2021 - 01/2006
2	ResveratrolIBA 11/2020 - 01/2015
2	Beclin-1IBA 01/2020 - 01/2018
2	erucylphosphocholineIBA 01/2020 - 10/2016
2	Electron Transport Complex I (NADH-CoQ Reductase)IBA 01/2020 - 01/2019
2	N-terminal proatrial natriuretic peptideIBA 11/2019 - 04/2007
2	Neprilysin (Neutral Endopeptidase)IBA 01/2018 - 06/2013
2	SodiumIBA 01/2017 - 07/2015
2	Antihypertensive Agents (Antihypertensives)IBA 06/2015 - 09/2012
2	DiureticsIBA 02/2014 - 01/2006
2	Vasodilator Agents (Vasodilators)IBA 02/2014 - 01/2006
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 06/2013 - 11/2002
1	Stromal Interaction Molecule 1IBA 01/2022
1	vericiguatIBA 11/2021
1	LipidsIBA 04/2021
1	SphingolipidsIBA 04/2021
1	Aminomethyltransferase (Glycine Synthase)IBA 01/2021
1	Genetic Markers (Genetic Marker)IBA 01/2021
1	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 12/2020
1	QuercetinIBA 11/2020
1	BerberineIBA 11/2020
1	CurcuminIBA 11/2020
1	Clostridium perfringens epsilon-toxinIBA 05/2020
1	ThymineIBA 01/2020
1	NAD (NADH)IBA 01/2020
1	Niacinamide (Nicotinamide)FDA LinkGeneric 01/2020
1	Nicotinamide MononucleotideIBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2020
1	Peptide Hydrolases (Proteases)FDA Link 02/2019
1	C-Type Natriuretic Peptide (Peptide, C-Type Natriuretic)IBA 02/2019
1	FurinIBA 02/2019
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	Pharmaceutical PreparationsIBA 10/2018
1	MetalsIBA 10/2018

Therapy/Procedure

8	Therapeutics 01/2022 - 07/2014
3	Percutaneous Coronary Intervention 10/2018 - 04/2016
2	Stents 10/2018 - 04/2016